Natural Peroxisome Proliferator-Activated Receptor γ (PPARγ) Activators for Diabetes.
Abstract
Context null Metabolic syndrome (MetS) represents a worldwide problem. Drugs used in MetS target different symptoms, like excessive body weight, insulin resistance, hyperglycemia, dyslipidemia, or hypertension. Peroxisome proliferator-activated receptors (PPAR) regulate the gene expression involved in lipid metabolism, inflammation, and adipogenesis. Activation of PPARγ has become a target of interest to counter hyperglycemia linked with MetS...
Paper Details
Title
Natural Peroxisome Proliferator-Activated Receptor γ (PPARγ) Activators for Diabetes.
Published Date
Jul 1, 2020
Volume
26
Pages
28 - 44
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History